Faster and more accurate diagnoses, better healthcare outcomes.

Our assays provide instant and highly accurate results and our mobile tracking app delivers data in real-time so that immediate and informed decisions about care can be made. Patients can self-quarantine, communities are in the know, and health care decision makers can take actionable steps to contain potential epidemics.

What makes IDX20 assays unique?

We combine rapid and highly accurate test results, affordability, ease of use, and real-time monitoring and data sharing. The lab-made reagents we utilize come from immune cells (B cells) of mammals exposed to the disease and from humans or animal reservoirs early in the epidemic cycle. We use these novel recombinant molecules with high detection performance to pathogens.

Products

1
2
3
Proprietary screening for antibodies, for high performance results against new threats.

Higher accuracy design with the added proprietary electric and magnetic properties of nanoparticles.

Results instantly shared, database and digital tracking systems connected to the point of care and execution of the tests.

INNOVATION

Sorry, your browser does not support inline SVG.
Then
Sorry, your browser does not support inline SVG.
2010-2017
Discovery of high throughput antibody screening platforms (patented)
Sorry, your browser does not support inline SVG.
2016
New method to rapidly build new diagnostics during outbreaks (patented)
Sorry, your browser does not support inline SVG.
2017-2020
First commercial prototypes for rapid test, and commercially available antibodies (patented)
Sorry, your browser does not support inline SVG.
2020-2021
Outbreak: Control expertise in bringing rapid Dx to market.
Sorry, your browser does not support inline SVG.
2017-2021
Development of new POC technologies (patented)
Sorry, your browser does not support inline SVG.
Now
WHY NOW?
POC testing is gaining traction. The market is already pivoting to home use. Our technology is now developed and we have years of combined academia and industry experience.

We are designing diagnostic technologies and deploying them for comprehensive, start to end solutions.

Leadership


Lee Gehrke
MIT Professor, Founder


Irene Bosch
CEO


Helena de Puig
Research and Development Leader

Let´s Talk!

Call Us
1 (617) 6861249
Email
company@idx20.us
Location
166 Clinton Rd. Brookline MA 02445
LinkedIn
IDX20d